Octozi is building AI-powered software to speed up and simplify how new medicines get to market. Today, bringing a drug to patients is a long, expensive process — often taking over a decade and billions of dollars. A major part of that time and cost comes from handling huge amounts of clinical trial data: information about how patients respond to new treatments, which researchers and regulators use to decide whether a drug is safe and effective. Right now, many of those data workflows are still manual, slow, and error-prone. Study teams—doctors, scientists, and data managers—spend countless hours cleaning spreadsheets, cross-checking reports, and responding to issues. This delays timelines and increases the risk of costly mistakes. Octozi automates those data workflows. Our platform connects with existing clinical systems, pulls in data in real time, and uses AI to flag issues, suggest corrections, and summarize key findings—much faster and more accurately than a human team alone.